Genotypic Characterization of Human Parvovirus B19 Circulating in the 2024 Outbreak in Tuscany, Italy
- PMID: 40005498
- PMCID: PMC11858505
- DOI: 10.3390/pathogens14020121
Genotypic Characterization of Human Parvovirus B19 Circulating in the 2024 Outbreak in Tuscany, Italy
Abstract
Human Parvovirus B19 (hB19V) is a widespread virus, causing erythema infectiosum in children and several clinical manifestations from acute to persistent infections in adults. In early 2024, ECDC reported an increased human Parvovirus B19 circulation in 14 European countries. A hB19V outbreak was also reported in Tuscany, Italy, prompting a detailed investigation of its genetic characteristics. In this context, through strict monitoring of circulating strains via next-generation sequencing (NGS), we carried out a phylogenetic analysis based on the whole of hB19V genomes. Phylogenetic clustering assigned all isolates to the G1a genotype, although with some mutations in NS1, VP1, and VP2, compared to the reference strains. Further characterization of these variants is necessary to fully assess their potential implications for public health. This study provides valuable insights into the spread of Parvovirus B19 and underlines the importance of continuous genomic surveillance to monitor and respond to possible hB19V epidemics that could impact public health.
Keywords: G1a genotype; Parvovirus B19; outbreak.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures



Similar articles
-
Genetic heterogeneity of the immunogenic viral capsid protein region of human parvovirus B19 isolates obtained from an outbreak in a pediatric ward.FEBS Lett. 1999 May 7;450(3):289-93. doi: 10.1016/s0014-5793(99)00518-9. FEBS Lett. 1999. PMID: 10359091
-
Virological characterization of Parvovirus B19 isolated during the atypical 2023-2024 outbreak in France.J Infect. 2025 Feb;90(2):106409. doi: 10.1016/j.jinf.2025.106409. Epub 2025 Jan 4. J Infect. 2025. PMID: 39761699
-
Insights into the clinical and molecular epidemiology of an infections outbreak of human parvovirus B19 in France, 2023-2024.J Clin Virol. 2025 Jun;178:105798. doi: 10.1016/j.jcv.2025.105798. Epub 2025 Apr 18. J Clin Virol. 2025. PMID: 40273548
-
Current molecular epidemiology and human parvovirus B19 infection.Pathol Biol (Paris). 2002 Jun;50(5):285-94. doi: 10.1016/s0369-8114(02)00305-x. Pathol Biol (Paris). 2002. PMID: 12116847 Review.
-
Antibody responses in parvovirus B19 infected patients.Pathol Biol (Paris). 2002 Jun;50(5):326-31. doi: 10.1016/s0369-8114(02)00302-4. Pathol Biol (Paris). 2002. PMID: 12116851 Review.
References
-
- Servey J.T., Reamy B.V., Hodge J. Clinical presentations of parvovirus B19 infection. Am. Fam. Physician. 2007;75:373–376. - PubMed
-
- Badrinath A., Gardere A., Samantha L., Palermo S.L., Campbell K.S., Kloc A. Analysis of Parvovirus B19 persistence and reactivation in human heart layers. Front. Virol. 2024;4:1304779. doi: 10.3389/fviro.2024.1304779. - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical